TY - JOUR AU - Mishra, Alok AU - Verma, Mukesh PY - 2019 TI - Prognostic value of epigenomic profiling in lung cancer JF - Translational Cancer Research; Vol 8, No 2 (April 30, 2019): Translational Cancer Research Y2 - 2019 KW - N2 - Among all types of lung cancers, non-small cell lung cancer (NSCLC) is the most common cause of cancer-associated death. Conventional therapy of NSCLC includes radiation, surgery, and cis-platin therapy. However, other approaches of treatment, including epigenetic therapy, have been proposed (1-4). UR - https://tcr.amegroups.org/article/view/28188